Literature DB >> 18579416

Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis.

W Z Wang1, X Guo, C Duan, W J Ma, Y G Zhang, P Xu, Z Q Gao, Z F Wang, H Yan, Y F Zhang, Y X Yu, J C Chen, M J Lammi.   

Abstract

OBJECTIVE: To investigate the differences in gene expression profiles of adult articular cartilage with endemic osteoarthritis (OA), Kashin-Beck disease (KBD), and the same regions in the normal joint.
METHODS: The messenger RNA expression profiles of articular cartilage with KBD diagnosed according to "Diagnosing Criteria of Kashin-Beck Disease in China" were compared with the normal cartilage. Total RNA isolated separately from four pairs of the KBD and normal cartilage samples were evaluated by oligonucleotide microarray analysis. The microarray data were confirmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) amplification and were compared with previously published experiments.
RESULTS: About 4100 transcripts, which corresponded to 35% of the expressed transcripts, showed >or=twofold differences in expression between the cartilage tissues in pairs. Approximately 2% of the expressed genes (79, 55 genes expressed in KBD>normal; 24 genes expressed in KBD<normal) were commonly expressed in the four pairs of samples. The expression of some genes related to the metabolism, apoptosis, cell proliferation and matrix degradation activity was significantly different in KBD cartilage than in the normal, similar to the findings for genes that inhibit matrix degradation. Comparisons of qRT-PCR data and the previously reported data with the result of gene chips support the validity of our microarray data.
CONCLUSION: Differences between KBD cartilage and the normal exhibited a similar pattern among the four pairs examined, indicating the presence of common mechanisms mainly including chondrocyte metabolism and apoptosis that contribute to cartilage destruction in KBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579416     DOI: 10.1016/j.joca.2008.05.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  36 in total

1.  Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.

Authors:  Xin Tang; Zongke Zhou; Bin Shen; Jing Yang; Pengde Kang; Jian Li; Nicolas Crook; Qi Li; Li Min; Fuxing Pei
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 2.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

3.  The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions.

Authors:  Santiago Vilar; George Hripcsak
Journal:  Brief Bioinform       Date:  2017-07-01       Impact factor: 11.622

4.  Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease.

Authors:  Feng Zhang; Xiong Guo; Yinping Zhang; Yan Wen; Weizhuo Wang; Sen Wang; Tielin Yang; Hui Shen; Xiangding Chen; Qing Tian; Lijun Tan; Hong-Wen Deng
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

5.  Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population.

Authors:  Quan-ming Zhao; Xiong Guo; Jiang-hua Lai; Wu-hong Tan; Wei-zhuo Wang; Xiao-qian Dang
Journal:  Clin Rheumatol       Date:  2012-03-20       Impact factor: 2.980

6.  The integrative analysis of DNA methylation and mRNA expression profiles confirmed the role of selenocompound metabolism pathway in Kashin-Beck disease.

Authors:  Ping Li; Yujie Ning; Weizhuo Wang; Xiong Guo; Blandine Poulet; Xi Wang; Yan Wen; Jing Han; Jingcan Hao; Xiao Liang; Li Liu; Yanan Du; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Cuiyan Wu; Sen Wang; Hongmou Zhao; Guanghui Zhao; Mary B Goldring; Feng Zhang; Peng Xu
Journal:  Cell Cycle       Date:  2020-08-20       Impact factor: 4.534

7.  Comparative analysis of signaling pathways in peripheral blood from patients with Kashin-Beck disease and osteoarthritis.

Authors:  Yujie Ning; Xi Wang; Sen Wang; Xiong Guo
Journal:  Exp Ther Med       Date:  2016-11-07       Impact factor: 2.447

8.  Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Authors:  Marina Sirota; Joel T Dudley; Jeewon Kim; Annie P Chiang; Alex A Morgan; Alejandro Sweet-Cordero; Julien Sage; Atul J Butte
Journal:  Sci Transl Med       Date:  2011-08-17       Impact factor: 17.956

Review 9.  Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretations.

Authors:  Jing Han; Weizhuo Wang; Chengjuan Qu; Ruiyu Liu; Wenrong Li; Zongqiang Gao; Xiong Guo
Journal:  Inflamm Res       Date:  2015-08-11       Impact factor: 4.575

10.  PAPSS2 promotes alkaline phosphates activity and mineralization of osteoblastic MC3T3-E1 cells by crosstalk and Smads signal pathways.

Authors:  Weizhuo Wang; Fang Li; Kunzheng Wang; Bin Cheng; Xiong Guo
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.